{"id":"https://openalex.org/W2008530776","doi":"https://doi.org/10.1248/bpb.b13-00963","title":"Differential Combined Effect of COX Inhibitors on Cell Survival Suppressed by Sorafenib in the HepG2 Cell Line","display_name":"Differential Combined Effect of COX Inhibitors on Cell Survival Suppressed by Sorafenib in the HepG2 Cell Line","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2008530776","doi":"https://doi.org/10.1248/bpb.b13-00963","mag":"2008530776","pmid":"https://pubmed.ncbi.nlm.nih.gov/24989014"},"language":"en","primary_location":{"id":"doi:10.1248/bpb.b13-00963","doi":"https://doi.org/10.1248/bpb.b13-00963","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b13-00963","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/37/7/37_b13-00963/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jstage.jst.go.jp/article/bpb/37/7/37_b13-00963/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091588945","display_name":"Kenta Yagi","orcid":"https://orcid.org/0000-0003-0869-5786","observed_orcids":["https://orcid.org/0000-0003-0869-5786"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenta Yagi","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087928519","display_name":"Yoichi Kawasaki","orcid":"https://orcid.org/0000-0002-3464-1522","observed_orcids":["https://orcid.org/0000-0002-3464-1522"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoichi Kawasaki","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082289640","display_name":"Hiroko Nakamura","orcid":"https://orcid.org/0000-0003-3036-7877","observed_orcids":["https://orcid.org/0000-0003-3036-7877"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroko Nakamura","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004305996","display_name":"Taro Miura","orcid":"https://orcid.org/0000-0002-3639-8220","observed_orcids":["https://orcid.org/0000-0002-3639-8220"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Taro Miura","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087778736","display_name":"Tatsuaki Takeda","orcid":"https://orcid.org/0000-0002-9872-2559","observed_orcids":["https://orcid.org/0000-0002-9872-2559"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuaki Takeda","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088413280","display_name":"Satoru Esumi","orcid":"https://orcid.org/0000-0002-2680-2277","observed_orcids":["https://orcid.org/0000-0002-2680-2277"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoru Esumi","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108608294","display_name":"Hisashi Matsunaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hisashi Matsunaga","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101577336","display_name":"Yoshihisa Kitamura","orcid":"https://orcid.org/0000-0002-3652-3722","observed_orcids":["https://orcid.org/0000-0002-3652-3722"]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihisa Kitamura","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109958742","display_name":"Toshiaki Sendo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100185","display_name":"Okayama University Hospital","ror":"https://ror.org/019tepx80","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210100185"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiaki Sendo","raw_affiliation_strings":["Department of Pharmacy, Okayama University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Okayama University Hospital","institution_ids":["https://openalex.org/I4210100185"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210100185"],"apc_list":null,"apc_paid":null,"fwci":0.6427,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.65023352,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"37","issue":"7","first_page":"1234","last_page":"1240"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.11209999769926071,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cyclooxygenase-inhibitors","display_name":"cyclooxygenase inhibitors","score":0.8569999933242798},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9610000252723694},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hepg2-cells","display_name":"HepG2 cells","score":0.9909999966621399},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":0.8519999980926514},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7310000061988831},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.593999981880188},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.8830000162124634},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7429999709129333},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.4729999899864197},{"id":"https://openalex.org/keywords/cell-survival","display_name":"cell survival","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9833847284317017},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6077516078948975},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6052267551422119},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.5847293138504028},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4859972894191742},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4683094918727875},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4535660445690155},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4184871017932892},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3738780617713928},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36316484212875366},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3475314974784851},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17372187972068787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07427087426185608}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/bpb.b13-00963","doi":"https://doi.org/10.1248/bpb.b13-00963","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b13-00963","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/37/7/37_b13-00963/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:24989014","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24989014","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/bpb.b13-00963","doi":"https://doi.org/10.1248/bpb.b13-00963","is_oa":true,"landing_page_url":"https://doi.org/10.1248/bpb.b13-00963","pdf_url":"https://www.jstage.jst.go.jp/article/bpb/37/7/37_b13-00963/_pdf","source":{"id":"https://openalex.org/S165235614","display_name":"Biological and Pharmaceutical Bulletin","issn_l":"0918-6158","issn":["0918-6158","1347-5215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biological and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2008530776.pdf","grobid_xml":"https://content.openalex.org/works/W2008530776.grobid-xml"},"referenced_works_count":54,"referenced_works":["https://openalex.org/W1499895161","https://openalex.org/W1543630008","https://openalex.org/W1774775070","https://openalex.org/W1923244951","https://openalex.org/W1964661764","https://openalex.org/W1965309017","https://openalex.org/W1966343985","https://openalex.org/W1971810008","https://openalex.org/W1976654542","https://openalex.org/W1980038534","https://openalex.org/W1980235624","https://openalex.org/W1990056225","https://openalex.org/W1991705951","https://openalex.org/W1994018922","https://openalex.org/W1994193851","https://openalex.org/W1995182877","https://openalex.org/W1998662458","https://openalex.org/W1999026714","https://openalex.org/W2002741555","https://openalex.org/W2008778808","https://openalex.org/W2013057063","https://openalex.org/W2023520601","https://openalex.org/W2027115372","https://openalex.org/W2027123549","https://openalex.org/W2032413424","https://openalex.org/W2042278655","https://openalex.org/W2043470852","https://openalex.org/W2052639292","https://openalex.org/W2056203710","https://openalex.org/W2056243205","https://openalex.org/W2063533719","https://openalex.org/W2068964056","https://openalex.org/W2070342988","https://openalex.org/W2079491773","https://openalex.org/W2081767554","https://openalex.org/W2083238673","https://openalex.org/W2100066495","https://openalex.org/W2104979424","https://openalex.org/W2111464526","https://openalex.org/W2114918609","https://openalex.org/W2116168419","https://openalex.org/W2118767258","https://openalex.org/W2120441162","https://openalex.org/W2126970264","https://openalex.org/W2132742086","https://openalex.org/W2135678285","https://openalex.org/W2136679918","https://openalex.org/W2137126095","https://openalex.org/W2142880257","https://openalex.org/W2151324279","https://openalex.org/W2171038529","https://openalex.org/W2267200853","https://openalex.org/W2303469300","https://openalex.org/W2405763068"],"related_works":["https://openalex.org/W2120441162","https://openalex.org/W2043470852","https://openalex.org/W2062125767","https://openalex.org/W4391530184","https://openalex.org/W2372300293","https://openalex.org/W2976155236","https://openalex.org/W2460401632","https://openalex.org/W2354599114","https://openalex.org/W3005145121","https://openalex.org/W4313642449"],"abstract_inverted_index":{"Hepatocellular":[0],"carcinoma":[1],"(HCC)":[2],"is":[3,17,24],"one":[4],"of":[5,9,41,49,66,76,79,88,98,101,132,140,145,157],"the":[6,39,42,61,89,95,138,143,158],"leading":[7],"causes":[8],"cancer-related":[10],"deaths":[11],"worldwide.":[12],"Sorafenib,":[13],"a":[14,18,27,77,99,119],"molecular-targeted":[15],"drug,":[16],"multi-target":[19],"oral":[20],"anti-neoplastic":[21],"drug":[22],"that":[23,162],"used":[25],"as":[26],"first-line":[28],"treatment":[29],"for":[30,172],"patients":[31],"with":[32,122,170],"advanced":[33],"Human":[34],"HCC.":[35],"An":[36],"increase":[37],"in":[38,73,168],"expression":[40,153],"cyclooxygenase-2":[43],"(COX-2)":[44],"protein":[45,152],"and":[46,81,103,117,135,147],"sequential":[47],"production":[48],"prostaglandin":[50],"(PG)":[51],"E2":[52],"were":[53],"previously":[54],"shown":[55],"to":[56,93],"significantly":[57,149],"enhance":[58],"carcinogenesis.":[59],"Although":[60],"synergistic":[62],"and/or":[63],"additive":[64],"effects":[65,97],"various":[67],"COX":[68,82,104,111,133,163],"inhibitors":[69,83,105,112,134,164],"have":[70],"been":[71],"demonstrated":[72],"HCC,":[74],"those":[75],"combination":[78,100,144,169],"sorafenib":[80,102,136,146,171],"remain":[84],"unclear.":[85],"The":[86,130,155],"aim":[87],"present":[90,159],"study":[91,160],"was":[92],"examine":[94],"antitumor":[96],"on":[106],"HCC":[107,173],"HepG2":[108,114],"cells.":[109],"Various":[110],"suppressed":[113],"cell":[115],"survival,":[116],"exhibited":[118],"combined":[120],"effect":[121],"sorafenib.":[123],"However,":[124],"COX-2":[125],"selectivity":[126],"had":[127],"little":[128],"relevance.":[129],"co-administration":[131],"increased":[137,150],"frequency":[139],"apoptosis.":[141],"Moreover,":[142],"diclofenac":[148],"Bax":[151],"levels.":[154],"results":[156],"indicate":[161],"can":[165],"be":[166],"administered":[167],"therapy.":[174]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}